Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 6NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Lymphoma 12Hodgkin Disease 11Urinary Bladder Neoplasms 7Urethral Neoplasms 3Melanoma 2Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1HIV Infections 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Astrocytoma 1

Interventions

Interferon-alpha 6Radiosurgery 4Dacarbazine 4encorafenib 3binimetinib 3aldesleukin 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Cisplatin 3Vinblastine 2Temozolomide 2Radiotherapy 2Polymerase Chain Reaction 2Nivolumab 2Ipilimumab 2Immunologic Techniques 2Flow Cytometry 2trametinib 1sulforaphane 1sargramostim 1romidepsin 1perifosine 1pembrolizumab 1peginterferon alfa-2b 1montanide ISA 51 1lorukafusp alfa 1incomplete Freund's adjuvant 1dipeptidase 1 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Melanoma × Vinblastine × Clear all
NCT00003027 2023-06-22

Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

Eastern Cooperative Oncology Group

Phase 3 Completed
482 enrolled
Dermatologic

Melanoma

NCT00006237 2015-03-25

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

SWOG Cancer Research Network

Phase 3 Completed
432 enrolled 7 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡